Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications

SHANGHAI, March 09, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the new drug applications (the “NDAs”) for the company’s product, toripalimab injection (subcutaneous injection [code: JS001sc]), for 12 indications in […]


play_arrow All Canada News
56 h.
Science
ID: 3312232951341683870


Similar News expand_more


2 w. Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD
Science
8 d. Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology
Science
4 w. Synaptive Medical Announces Formation of Clinical Advisory Board Comprised of Global Surgical and Imaging Leaders
Science
1 M. Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Science
1 w. Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First
Science
1 w. FDA approves HERNEXEOS®, the first targeted therapy for adults with HER2
Science
3 w. Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
Science
5 d. Portable MRI gives surgeon ‘instant feedback’ during brain tumour surgery
Science
2 w. Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution
Technology
3 w. Choisir le bon antibiotique plus rapidement à l’aide de la nanotechnologie
Science
3 w. Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend
Technology
1 M. InnoCare Announces IND Approval to Initiate Clinical Trial of VAV1 Degrader ICP
Technology
3 w. Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease
Science
4 w. Yatiri Bio Accurately Predicts AML Drug Response in Blinded Study Using Foghorn’s FHD
Science
6 h. Io Therapeutics, Inc. announces publication of studies on the company’s RXR agonist compound IRX4204 for breast cancer prevention
Science
4 d. L'aspirine, pilule miracle pour prévenir le cancer du côlon? Pas si vite!
Science
9 h. Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States
Science
1 w. Codetta Bio Announces Commercial Availability of Concerto™ System and New Customizable Cytokine and Neuroscience Panels at AGBT 2026
Science
6 d. The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Science
2 w. Un médecin influenceur quitte CBS en raison de ses échanges avec Epstein
Science
2 w. Les médecins spécialistes entament une nouvelle ronde de moyens de pression
Science
1 w. Les médecins spécialistes promettent des moyens de pression sans effets sur les rendez
Science
56 h. Medidata Expands Partnership with The Menarini Group, Deploying Medidata’s Study Build AI Technology to Accelerate Global Oncology Pipeline
Technology
9 h. Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy
Science
1 M. Rappel national d’un médicament contre l’hypertension: ce que vous devez savoir
Science
1 M. Niagen Bioscience is the Premiere Sponsor of the Inaugural “NAD for Health: Opportunities & Challenges” Conference Hosted by the University of Copenhagen
Science
4 w. Facet Life Sciences Publishes Second Edition of FDA and Intellectual Property Strategies for Medical Device Technologies
Technology
2 w. Trois primes aux médecins pour un seul patient: les infirmières spécialisées sous
Science
7 d. Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high
Technology
3 w. Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance
Technology
1 w. Les médecins spécialistes boycotteront le guichet unique pour les consultations
Science
1 M. Alexandra Diaz franchit une étape importante dans sa bataille contre le cancer
Science
2 w. La programmation d'Osheaga influencée par TikTok?: la gen Z ravie, les milléniaux moins
Science
3 w. Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway
Economics
2 w. Les IPS au sein d’un GMF pourront directement prendre des patients à leur charge
Science
7 d. Un Canadien sur 10 prend de l’Ozempic: un médicament utilisé pour les mauvaises raisons, selon un médecin
Science
7 h. CPAB Advances Transparency with Publication of Individual Firm Inspection Reports
Technology
2 w. PyroGenesis Confirms First Titanium Powder Order with Scientific Aerospace Research Organization
Technology
1 M. Vitamin B3 shows promise in halting brain cancer's return: U of C researchers
Science
1 w. Project 8 Mile nabs weapons and drugs, resulting in charges against six GTA men
Crime
4 w. U.K.’s First Commercial Biomethanol Bunkering Service Launches at Port of Immingham
Technology
1 h. Rad Source Technologies Announces Configurable Filters for the RS® 2000·Q2 Biological Irradiator
Technology
3 w. Omantel launches “Otech,” the Provider of Technologies of the Future and Enabler of Digital Transformation, and signs strategic partnerships
Technology
1 M. «Oui, je suis tombée dans les pilules», confie Caroline Néron, qui dit avoir lutté contre une dépendance aux anxiolytiques
Science
3 w. Yanik Guillemette Announces Major Accolad Integration to Automate Referral Payments and Commercial Incentives
Economics
1 M. Boxe: Imane Khelif révèle avoir pris un traitement hormonal avant les JO de France en 2024
Science
2 w. Lithium Americas Provides a Project Update and 2026 Capex Guidance for Thacker Pass
Technology
3 w. Wearable Devices Ltd. (NASDAQ: WLDS) Launches Platform to Address Critical Gap in AI Intent Capture
Technology
1 M. Plaid Technologies Appoints Dr. Ian Flint as Technical Advisor to Support Commercialization of Graphene Technologies
Technology
Popular countries based on strong economic and political relations
Add Watch Country

arrow_drop_down